Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypothalamic-Pituitary-Adrenal (HPA)/ Dopamine Axis in Psychotic Depression

NCT00576095 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00576095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00576095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypothalamic-Pituitary-Adrenal (HPA)/ Dopamine Axis in Psychotic Depression
Lead sponsor
Stanford University
Phase
Observational
Overall status
Completed
Start date
August 31, 2005
Completion date
June 30, 2012
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depressive disorder, major, psychotic disorders